Of note, genetic inactivation of DOT1L in blast-phase MPN led to a change in cell identity features, including loss of erythroid lineage genes and HOX-genes as well as an upregulation of programs related to antigen presentation and immune activation (Supplementary Fig. 1D,E). This evidence concerns the gene DOT1L and myeloproliferative disorder.